Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here
Pricing and Ordering Information
ClearState

China Dermatosis Drug Market Report 2008
Report #DHP9003 - February 2009

Dermatosis diseases are common diseases in China with high incidence and recurrence rates. The dermatosis disease rate is about 1.23%, meaning that there are about 160 million Chinese dermatosis patients. Dermatosis drugs are ranked as the No. 3 best selling drug category (by retail sales volume) in China. There are more than 600 dermatosis drugs for external use in the Chinese drug retail market. The market size of the Chinese dermatosis drug market in 2007 is about USD $1.39 billion with a same period growth of 16.73%.

This report has systemically analyzed the Chinese dermatosis drug market. All calculations of drug utilization in China are based on hospital drug prescription and drug purchasing data from the hospital data monitor system that the China Nan Fang Institute of Medical and Economic Information has developed and maintained (Nan Fang Institute is a direct subsidiary of the Chinese State Food and Drug Administration, the SFDA). Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Xian, Shenyang, Harbin and Zhengzhou, covering significant percentages of all hospitals in these regions (20-60% of hospital beds coverage).

This China Dermatosis Drug Market Report has been a must have reference for decision makers in pharmaceutical companies, medical device companies, healthcare investing companies and healthcare consulting companies. These unique drug prescription and utilization data can provide valuable information for new product development, marketing and strategic planning functions for pharmaceutical companies.

Ordering Information

Title

 Report# Publication
Date		 List Price

China Dermatosis Drug Market Report 2008

DHP9003

 February 2009

$8,000
Order Online:
Single User only (Please call for corporate subscription pricing)		   Print + PDF PDF Only

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

THE TOP 20 PHARMACEUTICAL COMPANIES IN THE CHINESE DERMATOSIS DRUG MARKET 2007 (AT LEAST >1.17% OF THE CHINA DERMATOSIS DRUG MARKET SHARES)

Methodology for the Annual China Drug Market Reports

Key Drug Data For Each of These 18 Therapeutic Areas in China

List of Annual China Drug Market Reports 2008

Prologue

Chapter I:       Summary of Dermatosis Drugs

Section 1:  Current Clinical Utilization of Dermatosis Drugs in China

1.               Major Anti-fungus Dermatosis Drugs

2.   Major Types of Cortical Hormone Dermatosis Drugs

3.   Major Dermatosis Drugs for Infectious Dermatosis and Major Disinfectants

4.   Major Dermatosis Drugs for Psoriasis Treatment

Section 2:  Classifications of Dermatosis drugs

1.               Systemic Drug

2.               External Treatment of Dermatosis Diseases

3.               Physical Therapy for Dermatosis Diseases

Chapter II:      Summary of The Dermatosis Drug Market

Section 1:  Global Market of Dermatosis Drugs

1.   Forecast of the Allergic Dermatitis Market

2.   Forecast of the US Psoriasis Drug Market

3.   Global Market for Burn Treatment Drugs surpassed USD 1.5 billion

Section 2:  The Chinese Market of Dermatosis Drugs

Section 3:  Market Shares of Dermatosis Drug categories in China

Section 4:  Market Shares of the Top 20 Dermatosis Drugs in China 2005-2007

Section 5:  Market Shares of the Top 20 Manufacturers in the Chinese Dermatosis Drug Market 2005-2007

Section 6:  Growth Rates of the Top 20 Dermatosis Drugs 2006-2007

Section 7:  Market Potentials of Key Dermatosis Drugs in China

Chapter III:    Market Sizes and Growths of Key Dermatosis Drugs in China

Section 1:  Top 5 Dermatosis Drugs in Each Category (11 categories)

Section 2:  Top 10 Best Selling Brand Dermatosis Drugs 2006-2007

1.   Market Shares, Market Sizes and Manufacturers of Terbinafine

2.   Market Shares, Market Sizes and Manufacturers of Mometasone

3.   Market Shares, Market Sizes and Manufacturers of Povidone Iodide

4.   Market Shares, Market Sizes and Manufacturers of Econazole

5.   Market Shares, Market Sizes and Manufacturers of Halometasone (Halometasone/Triclosan)

6.   Market Shares, Market Sizes and Manufacturers of Hydrocortisone Butyrate

7.   Market Shares, Market Sizes and Manufacturers of Miconazole Nitrate

8.   Market Shares, Market Sizes and Manufacturers of Mupirocin

9.   Market Shares, Market Sizes and Manufacturers of Viaminate (Viaminate/vitaminE)

10. Market Shares, Market Sizes and Manufacturers of Calcipotriol

Chapter IV:     List of Brand Names, Generic Names, Formula & Manufacturers of Dermatosis Drugs in China

Chapter V:       Dermatosis Drugs on the National Healthcare Insurance Coverage List

Section 1:  Dermatosis Drugs on the National Basic Healthcare Insuracne List

1.   Chemical Dermatosis Drugs on the National Basic Healthcare Insurance List

2.   Traditional Chinese Medicine (TCM) Dermatosis Drugs on the National Basic Healthcare Insurance List

Chapter VI:     R & D of Dermatosis Drugs

Section 1:  New Dermatosis Drugs Approved in 2007

Section 2:  New Dermatosis Drugs under Development

1.   Ustekinumab

2.   Enbrel

Section 3:  Advancement of Dermatology Study in China

1.   Transition from the Traditional Dermatology to Modern Dermatology

2.   The Invention of Local Immunomodulator

3.   Biologics for Psoriasis Treatment

4.   Photo-therapy - Ultraviolet Radiation

5.   Genetic Mutation Studies on the Genetic Dermatosis Diseases

6.   Breakthrough in the Understanding of the Disease Development Mechanism of Paraneoplastic Pemphigus

7.   Development of Photo Sensitizer

8.   Anti-fungal Drugs

9.   Laser Cosmetic Technology

Exhibitions

Table 1:     Common Corticosteroid Drugs and Dosages

Table 2:     Common Antihistamine Drugs (H2 Receptor Antagonist)

Table 3:     Common Corticosteroid Drugs and Dosages

Table 4:     Market Shares of Dermatosis Drugs by Category 2002-2007

Table 5:     Market Shares of Key Dermatosis Drugs in China 2005-2007

Table 6:     Market Shares of the Top 20 Manufacturers in the Chinese Dermatosis Drug Market 2005-2007

Table 7:     Market Share Growths of Key Dermatosis Drugs 2005-2007

Table 8:     Top 5 Dermatosis Drugs by Category (By Sales Revenue) in 2006

Table 9:     Top 5 Dermatosis Drugs by Category (By Sales Revenue) in 2007

Table 10:   Market Shares and Manufacturers of Terbinafine 2005-2007

Table 11:   Market Sizes and Manufacturers of Terbinafine 2006-2007

Table 12:   Market Shares and Manufacturers of Mometasone 2005-2007

Table 13:   Market Sizes and Manufacturers of Mometasone 2006-2007

Table 14:   Market Shares and Manufacturers of Povidone Iodide 2005-2007

Table 15:   Market Sizes and Manufacturers of Povidone Iodide 2006-2007

Table 16:   Market Shares and Manufacturers of Econazole 2005-2007

Table 17:   Market Sizes and Manufacturers of Econazole 2006-2007

Table 18:   Market Shares and Manufacturers of Halometasone and Its Compound Preparations 2005-2007

Table 19:   Market Sizes and Manufacturers

Table 20:   Market Shares and Manufacturers of Miconazole Nitrate 2005-2007

Table 21:   Market Sizes and Manufacturers of Miconazole Nitrate 2006-2007

Table 22:   Market Sizes and Manufacturers of Viaminate 2005-2007

Table 23:   Market Sizes and Manufacturers of Viaminate 2006-2007

Table 24:   Brand Names, Generic Names, Formulas and Manufacturers of Dermatosis Drugs in China

Table 25:   Chemical Dermatosis Drugs on the National Basic Healthcare Insurance List

Table 26:   Traditional Chinese Medicine (TCM) Dermatosis Drugs on the National Basic Healthcare Insurance List

Table 27:   New Dermatosis Drugs Approved in 2007

 

Table A:     Hospital Coverage for the Monitoring and Tracking of Drug Prescription and Purchasing Data in China (Nan Fang Institute)

Figure 1:    Market Sizes and Growth Rates of the Chinese Dermatosis Drug Market 2002-2007

Figure 2:    Market Sizes and Sales Growths of Oral vs. External Use Dermatosis Drugs 2002-2007

Figure 3:    Market Potential of Key Dermatosis Drugs

Figure 4:    Market Shares of the Top 10 Dermatosis Drugs in China 2006

Figure 5:    Market Shares of the Top 10 Dermatosis Drugs in China 2007

THE TOP 20 PHARMACEUTICAL COMPANIES IN THE CHINESE DERMATOSIS DRUG MARKET 2007

(At least >1.17% of the China Dermatosis Drug Market Shares)

Chongqing Huabang

Novartis

Xian-Janssen

Daiichi Seiyaku

Tianjin Pharmaceutical

Hong Kong Bright Future

Schering-Plough China

Tianjin SmithKline & French Laboratories Ltd.

Shandong Qilu

LEO Pharmaceutical

Laboratories Galderma S.A

Shanghai Likang

Shanghai Xinyi

Luitpold-Werk, Chemisch-Pharma, Fabrik

Bayer

Jiangsu Jichuan

Teijin Limited

Sichuan Dikang

Zhejiang Hangzhou Yishute

GSK

 

Draco Healthcare Consulting is the leader in the China-focused healthcare consulting business. They serve leading pharmaceutical and biotech companies both inside and outside of China to make better medicines for China. www.dracohealthcare.com

*The print version of this report costs an additional $500 when purchased in addition to the PDF.

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home